Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSYR.L Regulatory News (SYR)

  • There is currently no data for SYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SYNERGY HEALTH PLC

26 Oct 2015 14:12

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose

SYNERGY HEALTH PLC

relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 23 October 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? STERIS CORPORATION

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,965,202 3.32% 10,643 0.02%
(2) Cash-settled derivatives:
869 0.00% 1,965,202 3.32%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,966,071 3.32% 1,975,845 3.34%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 10 23.3100 GBP
ORD Purchase 35 23.1100 GBP
ORD Purchase 62 23.3400 GBP
ORD Purchase 201 23.3350 GBP
ORD Purchase 221 23.3550 GBP
ORD Purchase 235 23.3450 GBP
ORD Purchase 263 23.3300 GBP
ORD Purchase 271 23.3000 GBP
ORD Purchase 273 23.3250 GBP
ORD Purchase 299 23.3050 GBP
ORD Purchase 301 23.3500 GBP
ORD Purchase 368 23.2950 GBP
ORD Purchase 386 23.3565 GBP
ORD Purchase 488 23.3150 GBP
ORD Purchase 687 23.3039 GBP
ORD Purchase 899 23.3033 GBP
ORD Purchase 1,041 23.4000 GBP
ORD Purchase 1,105 23.3600 GBP
ORD Purchase 1,243 23.3099 GBP
ORD Purchase 1,496 23.0208 GBP
ORD Purchase 1,616 23.3525 GBP
ORD Purchase 1,916 23.1994 GBP
ORD Purchase 2,203 23.3763 GBP
ORD Purchase 3,945 23.2756 GBP
ORD Purchase 8,284 23.3027 GBP
ORD Purchase 26,831 23.3197 GBP
ORD Purchase 68,414 23.2566 GBP
ORD Sale 10 23.3100 GBP
ORD Sale 35 23.1100 GBP
ORD Sale 62 23.3400 GBP
ORD Sale 71 23.0800 GBP
ORD Sale 201 23.3350 GBP
ORD Sale 221 23.3550 GBP
ORD Sale 235 23.3450 GBP
ORD Sale 263 23.3300 GBP
ORD Sale 271 23.3000 GBP
ORD Sale 273 23.3250 GBP
ORD Sale 299 23.3050 GBP
ORD Sale 347 23.3500 GBP
ORD Sale 368 23.2950 GBP
ORD Sale 483 23.3111 GBP
ORD Sale 488 23.3150 GBP
ORD Sale 687 23.3039 GBP
ORD Sale 755 23.3045 GBP
ORD Sale 899 23.3033 GBP
ORD Sale 1,041 23.4000 GBP
ORD Sale 1,105 23.3600 GBP
ORD Sale 1,245 23.3097 GBP
ORD Sale 1,245 23.3483 GBP
ORD Sale 1,403 23.0149 GBP
ORD Sale 8,284 23.3027 GBP
ORD Sale 39,832 23.3148 GBP
ORD Sale 75,277 23.2668 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Long 2 23.2050 GBP
ORD SWAP Long 4,838 23.3011 GBP
ORD CFD Short 128 23.1131 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 26 Oct 2015
Contact name: RAJESH MUTHANNA
Telephone number: 020 3555 4634

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151026005904/en/

Copyright Business Wire 2015

Date   Source Headline
2nd Nov 20153:51 pmRNSScheme Effective
2nd Nov 20152:55 pmRNSForm 8.3 - Steris Corporation
2nd Nov 20152:50 pmRNSForm 8.3 - Steris Corporation
2nd Nov 20151:55 pmRNSForm 8.3 - Steris Corporation
2nd Nov 20151:41 pmRNSForm 8.3 - Steris Corporation
2nd Nov 201512:08 pmRNSForm 8.3 - Synergy Health Plc
30th Oct 20152:47 pmRNSForm 8.3 - Steris Corporation
30th Oct 20152:07 pmRNSForm 8.3 - Steris Corporation
30th Oct 20151:58 pmRNSForm 8.3 - Steris Corporation
30th Oct 20151:00 pmRNSForm 8.3 - Synergy Health Plc
30th Oct 201511:25 amRNSForm 8.3 - Steris Corp
30th Oct 201511:22 amRNSForm 8.3 - Steris Corporation Replacement
30th Oct 201511:15 amRNSForm 8.3 - Steris Corporation
30th Oct 201511:00 amRNSHalf Yearly Report
30th Oct 201510:30 amRNSHalf Yearly Report
30th Oct 20157:00 amRNSForm 8.3 - Steris Corp.
30th Oct 20157:00 amRNSForm 8 (DD) - STERIS Corporation
29th Oct 20155:40 pmRNSForm 8.3 - Steris Corporation
29th Oct 20155:32 pmRNSForm 8.3 - Steris Corporation Plc
29th Oct 20152:18 pmRNSForm 8.3 - Steris Corporation
29th Oct 20151:52 pmRNSForm 8.3 - Steris Corporation
29th Oct 20151:50 pmRNSForm 8.3 - Steris Corp
29th Oct 20151:42 pmRNSForm 8.3 - Synergy Health Plc
29th Oct 20151:27 pmRNSForm 8.3 - Steris Corporation
29th Oct 20157:00 amBUSForm 8.3 - Synergy Health
28th Oct 20154:43 pmRNSResults of Court Hearing
28th Oct 20154:17 pmBUSForm 8.3 - SYNERGY HEALTH PLC
28th Oct 20153:29 pmRNSForm 8.3 - [Synergy Health Plc]
28th Oct 20153:24 pmRNSForm 8.3 - Synergy Health PLC
28th Oct 20153:00 pmRNSForm 8.3 - Synergy Health PLC
28th Oct 20152:47 pmBUSForm 8.3 - Synergy Health Plc
28th Oct 20152:09 pmRNSForm 8.3 - Steris Corporation
28th Oct 20151:36 pmRNSForm 8.3 - Synergy Health Plc
28th Oct 20151:21 pmRNSForm 8.3 - Steris Corp
28th Oct 20151:19 pmRNSForm 8.3 - Synergy Health Plc
28th Oct 20151:06 pmRNSForm 8.3 - Synergy Health PLC
28th Oct 20151:05 pmRNSForm 8.3 - Steris Corporation
28th Oct 201512:47 pmRNSForm 8.3 - Synergy Health Plc
28th Oct 201511:56 amRNSForm 8.3 - [Synergy Health Plc/Steris Corporation]
28th Oct 201511:52 amRNSForm 8.3 - [Synergy Health Plc/Steris Corporation]
28th Oct 201511:15 amRNSHolding(s) in Company
28th Oct 201510:29 amRNSForm 8 (DD) - Synergy Health plc
28th Oct 201510:27 amRNSForm 8 (DD) - Synergy Health plc
28th Oct 201510:25 amRNSForm 8 (DD) - Synergy Health plc
28th Oct 20157:30 amRNSSuspension Synergy Health Plc
28th Oct 20157:00 amRNSSuspension of trading and listing of Synergy Share
27th Oct 20154:14 pmBUSForm 8.3 - Synergy Health Plc
27th Oct 20153:25 pmRNSForm 8.3 - Synergy Health plc
27th Oct 20153:19 pmBUSForm 8.3 - Synergy Health Plc
27th Oct 20153:01 pmRNSForm 8.3 - Synergy Health PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.